3D Printed Drugs Market is growing at a CAGR of 4.2% over the forecast period | Size & AnalysisThe 3D Printed Drugs Market is growing at a CAGR of 4.2% over the forecast period.
For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/global-3d-printed-drugs-market-by-technique-type/
The factors driving growth of the 3D Printed Drugs Market includes increasing geriatric population around the world, growing demand for soluble drugs, rising prevalence of stroke, Alzheimer's disease and head and neck tumors and improvements in the living standards. For instance, the population aged 60 and above across India was calculated around 138 million in 2021 and is expected to reach 194 million by the end of 2031, which is expected to accelerate the 3D Printed Drugs Market size in the approaching years. Moreover, growing adoption of advanced technologies by manufacturers, rise in Government spending to enhance the healthcare infrastructure, increasing popularity of personalized drugs across the globe and rapid urbanization, are some of the additional factors supplementing the Global 3D Printed Drugs Market. In addition, the increasing investments by major companies on research and development, strategic partnerships, and collaborations between key industry players, rise in the launch of innovative products and growing disposable incomes, are further contributing towards the market growth.
However, lack of Government regulations regarding the manufacturing of 3D printed drugs, might hamper the market growth.
The major players operating in the market are Merck KGaA, Hewlett Packard Caribe, Cycle Pharmaceuticals, Aprecia Pharmaceuticals LLC, GlaxoSmithKline Plc., FabRx Ltd., and Tvasta, among others.
Based on Type, the Fused Deposition Modelling segment is predicted to expand at a remarkable CAGR during the forecast period
Fused deposition modelling shortens time to print 3D and speeds up the prototyping process, are pushing growth of the segment.
On the other hand, the Inkjet Printing Infant segment is projected to hold the highest market share during the forecast period. Inkjet printing helps in produces 3D Drugs tablets, along with rising incidences of epilepsy, are pushing growth of the segment.
Based on Region, the Asia-Pacific region is expected to capture the largest market share over the forecast period
Government polices promoting the manufacturing of pharmaceutical products, increased adoption of advanced technologies by manufacturers, rapid industrialization, growing prevalence of Alzheimer's disease and high population growth rates, are some of the important factors augmenting the market growth in the Asia-Pacific region.
In 2020, Aprecia Pharmaceuticals LLC signed an agreement with the Purdue University's College of Pharmacy for advace technologies and science of 3D pharmaceutical printing. The companies planned to focus on developing future 3D printed pharmaceutical equipment and medications.
In 2020, Merck KGaA signed an agreement with Additive Manufacturing Customized Machines (AMCM) to develop a prototype printer, which is projected to be completed towards the end of 2020.
In 2018, Cycle Pharmaceuticals entered into a partnership with US-based Aprecia Pharmaceuticals for the development and commercialization of drugs for rare diseases using 3D printed technology. It will further helps to deliver quality of life improvements over existing approved orphan drugs.
Segmentation by Technique Type
Fused Deposition Modelling
Inkjet Printing Infant
Selective Laser Sintering
Segmentation by Region
Rest of APAC
United States of America
Rest of Europe
About GMI Research
GMI Research is a market research and consulting firm which provides market insights and intelligence across 12 major sectors helping our clients in making effective investment and business decisions.
Company Name: GMI RESEARCH
Contact Person: Sarah Nash
Phone: Europe - +353 1 442 8820; US - +1 860 881 2270
Address: Dublin, Ireland
Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate, Dublin D18 Y3X2, Ireland
GMI Research's leadership team with extensive experience in research and consulting together with our research and domain expertise creates a strong value proposition to create solutions that addresses our clients business problems and add significant value to long lasting relationship.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 3D Printed Drugs Market is growing at a CAGR of 4.2% over the forecast period | Size & Analysis here
News-ID: 3092704 • Views: 708
More Releases from GMI Research
OLED Market is projected to rise at a higher CAGR during the forecast period | S …
The OLED Market is anticipated to expand at a remarkable CAGR during the forecast period For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/global-oled-market/ The factors driving growth of the OLED Market includes increasing penetration of smartphones and gaming consoles around the world, Government policies supporting OLED lighting research, growing popularity of smart Televisions and improvements in the living standards. For instance, the revenue generated from the sales of video game consoles
Virtual Private Cloud Market is expected to grow at a higher CAGR of 23.4% over …
The Virtual Private Cloud Market is projected to grow at a CAGR of 23.4% over the forecast period. For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/global-virtual-private-cloud-market/ The factors driving growth of the Virtual Private Cloud Market includes huge volumes of data generated across BSFI, Healthcare and Media & Entertainment industries, rising focus by companies on modernizing IT infrastructure, Government initiatives promoting digitalization, increasing number of data breaches reported around the
Pest Control Services Market is poised to grow at a robust CAGR during the forec …
The Pest Control Services Market is estimated to grow at a robust CAGR over the forecast period For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/pest-control-services-market/ The factors driving growth of market includes increasing demand for pest control services from hospitality, pharmaceutical, and food processing industries, growing focus on using biocides, rising concerns related to climate change, and improvements in the living standards. For instance, the market value of biocides worldwide was
Membrane Filtration Market is projected to grow at a higher CAGR of 6.3% during …
The Membrane Filtration Market is slated to register at a CAGR of 6.3% over the forecast period. For Additional Insights, Click to Access Complete Report - https://www.gmiresearch.com/report/membrane-filtration-market/ The factors driving growth of the Membrane Filtration Market includes strict regulations imposed by Governments regarding water safety, growing demand for dairy products around the world, increasing use of membrane filters to sterilize gas and liquids and improvements in the living standards. Moreover, expansion of
More Releases for Drugs
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$
Prospect of Global Excipients Market Research Report 2017 with Application inclu …
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database. In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests. On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.